BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34906547)

  • 1. Enhanced expression of pentraxin-3 in glioblastoma cells correlates with increased invasion and IL8-VEGF signaling axis.
    Wesley UV; Sutton I; Clark PA; Cunningham K; Larrain C; Kuo JS; Dempsey RJ
    Brain Res; 2022 Feb; 1776():147752. PubMed ID: 34906547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of pentraxin 3 in glioma cells impairs proliferation and invasion in vitro and in vivo.
    Tung JN; Ko CP; Yang SF; Cheng CW; Chen PN; Chang CY; Lin CL; Yang TF; Hsieh YH; Chen KC
    J Neurooncol; 2016 Sep; 129(2):201-9. PubMed ID: 27278519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cells.
    O'Neill CL; Guduric-Fuchs J; Chambers SE; O'Doherty M; Bottazzi B; Stitt AW; Medina RJ
    Cardiovasc Res; 2016 Dec; 112(3):677-688. PubMed ID: 27659714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway.
    Rathore M; Girard C; Ohanna M; Tichet M; Ben Jouira R; Garcia E; Larbret F; Gesson M; Audebert S; Lacour JP; Montaudié H; Prod'Homme V; Tartare-Deckert S; Deckert M
    Oncogene; 2019 Jul; 38(30):5873-5889. PubMed ID: 31253871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12.
    Margheri F; Serratì S; Lapucci A; Chillà A; Bazzichi L; Bombardieri S; Kahaleh B; Calorini L; Bianchini F; Fibbi G; Del Rosso M
    Arthritis Rheum; 2010 Aug; 62(8):2488-98. PubMed ID: 20506099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long pentraxin PTX3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas.
    Locatelli M; Ferrero S; Martinelli Boneschi F; Boiocchi L; Zavanone M; Maria Gaini S; Bello L; Valentino S; Barbati E; Nebuloni M; Mantovani A; Garlanda C
    J Neuroimmunol; 2013 Jul; 260(1-2):99-106. PubMed ID: 23664694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particulate matter-mediated release of long pentraxin 3 (PTX3) and vascular endothelial growth factor (VEGF) in vitro: Limited importance of endotoxin and organic content.
    Herseth JI; Volden V; Bolling AK
    J Toxicol Environ Health A; 2017; 80(2):105-119. PubMed ID: 28071984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL‑1β‑induced pentraxin 3 inhibits the proliferation, invasion and cell cycle of trophoblasts in preeclampsia and is suppressed by IL‑1β antagonists.
    Wang X; Zhang J; Ji J
    Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35137920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin 3 acts as a functional effector of Akt/NF-κB signaling to modulate the progression and cisplatin-resistance in non-small cell lung cancer.
    Li Y; Song X; Niu J; Ren M; Tang G; Sun Z; Kong F
    Arch Biochem Biophys; 2021 Apr; 701():108818. PubMed ID: 33617838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
    Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
    Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of long pentraxin 3 in human nasal mucosa fibroblasts, tissues, and secretions of chronic rhinosinusitis without nasal polyps.
    Tsai YJ; Hao CY; Chen CL; Wu PH; Wu WB
    J Mol Med (Berl); 2020 May; 98(5):673-689. PubMed ID: 32239253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A
    Yan A; Joachims ML; Thompson LF; Miller AD; Canoll PD; Bynoe MS
    J Neurosci; 2019 May; 39(22):4387-4402. PubMed ID: 30926752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.
    Ronca R; Di Salle E; Giacomini A; Leali D; Alessi P; Coltrini D; Ravelli C; Matarazzo S; Ribatti D; Vermi W; Presta M
    Mol Cancer Ther; 2013 Dec; 12(12):2760-71. PubMed ID: 24130051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXCL2/IL8/CXCR2 Pathway Is Relevant for Brain Tumor Malignancy and Endothelial Cell Function.
    Urbantat RM; Blank A; Kremenetskaia I; Vajkoczy P; Acker G; Brandenburg S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis.
    Rusnati M; Camozzi M; Moroni E; Bottazzi B; Peri G; Indraccolo S; Amadori A; Mantovani A; Presta M
    Blood; 2004 Jul; 104(1):92-9. PubMed ID: 15031207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells.
    Ying TH; Lee CH; Chiou HL; Yang SF; Lin CL; Hung CH; Tsai JP; Hsieh YH
    Sci Rep; 2016 Jul; 6():29385. PubMed ID: 27377307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.
    Choi B; Lee EJ; Song DH; Yoon SC; Chung YH; Jang Y; Kim SM; Song Y; Kang SW; Yoon SY; Chang EJ
    Oncotarget; 2014 Jan; 5(2):481-92. PubMed ID: 24457902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor endothelial cells express high pentraxin 3 levels.
    Hida K; Maishi N; Kawamoto T; Akiyama K; Ohga N; Hida Y; Yamada K; Hojo T; Kikuchi H; Sato M; Torii C; Shinohara N; Shindoh M
    Pathol Int; 2016 Dec; 66(12):687-694. PubMed ID: 27862647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human retinal pigment epithelial cells express the long pentraxin PTX3.
    Woo JM; Kwon MY; Shin DY; Kang YH; Hwang N; Chung SW
    Mol Vis; 2013; 19():303-10. PubMed ID: 23401658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long pentraxin PTX3 is upregulated systemically and centrally after experimental neurotrauma, but its depletion leaves unaltered sensorimotor deficits or histopathology.
    Oggioni M; Mercurio D; Minuta D; Fumagalli S; Popiolek-Barczyk K; Sironi M; Ciechanowska A; Ippati S; De Blasio D; Perego C; Mika J; Garlanda C; De Simoni MG
    Sci Rep; 2021 May; 11(1):9616. PubMed ID: 33953334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.